Bangkok Genomics Innovation PCL (BKK:BKGI) Price-to-Free-Cash-Flow : 85.14 (As of May. 10, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL Price-to-Free-Cash-Flow?

As of today (2024-05-10), Bangkok Genomics Innovation PCL's share price is ฿2.98. Bangkok Genomics Innovation PCL's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2023 was ฿0.04. Hence, Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow Ratio for today is 85.14.

The historical rank and industry rank for Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow or its related term are showing as below:

BKK:BKGI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 73.71 Med: 84.57 Max: 155.71
Current: 85.14

During the past 5 years, Bangkok Genomics Innovation PCL's highest Price-to-Free-Cash-Flow Ratio was 155.71. The lowest was 73.71. And the median was 84.57.

BKK:BKGI's Price-to-Free-Cash-Flow is ranked worse than
85.56% of 90 companies
in the Medical Diagnostics & Research industry
Industry Median: 26.755 vs BKK:BKGI: 85.14

Bangkok Genomics Innovation PCL's Free Cash Flow per Share for the three months ended in Mar. 2023 was ฿0.04. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ฿0.04.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Bangkok Genomics Innovation PCL was 26.10% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 83.40% per year.

During the past 5 years, Bangkok Genomics Innovation PCL's highest 3-Year average Free Cash Flow per Share Growth Rate was 83.40% per year. The lowest was 83.40% per year. And the median was 83.40% per year.

Bangkok Genomics Innovation PCL Price-to-Free-Cash-Flow Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL Price-to-Free-Cash-Flow Chart

Bangkok Genomics Innovation PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Free-Cash-Flow

Bangkok Genomics Innovation PCL Quarterly Data
	Dec20	Dec21	Mar22	Dec22	Mar23	Dec23
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow falls into.

Bangkok Genomics Innovation PCL Price-to-Free-Cash-Flow Calculation

Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	2.98	/	0.035
	=	85.14

Bangkok Genomics Innovation PCL's Share Price of today is ฿2.98.
Bangkok Genomics Innovation PCL's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.04.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Bangkok Genomics Innovation PCL (BKK:BKGI) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Bangkok Genomics Innovation PCL Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Bangkok Genomics Innovation PCL (BKK:BKGI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110

Website

https://www.bangkokgenomics.com

Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products).